Company / Assets per Share
PharmaCyte Biotech, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.86
FY2025
5-year range
$3.54 / $56.99
FY2021-FY2025
Trend
+92.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2020 to $56.99 in FY2022.
Based on SEC 10-K filings.
6.86 in FY2025 with a 5-year CAGR of +320.8%.
Improved from $3.54 to $6.86 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -50.6%
- 5-Year CAGR
- +320.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 92.4% year-over-year.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.86 | +92.4% |
| FY2024 | $3.57 | +0.9% |
| FY2023 | $3.54 | -93.8% |
| FY2022 | $56.99 | +740.9% |
| FY2021 | $6.78 | +130254.5% |
| FY2020 | $0.01 | -8.9% |
| FY2019 | $0.01 | -19.4% |
| FY2018 | $0.01 | -36.2% |
| FY2017 | $0.01 | +13.5% |
| FY2016 | $0.01 | -27.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026